Basit öğe kaydını göster

dc.contributor.authorÇetin, Mustafa
dc.contributor.authorÖzer, Savaş
dc.contributor.authorCinier, Göksel
dc.contributor.authorYılmaz, Ahmet Şeyda
dc.contributor.authorErdoğan, Turan
dc.contributor.authorSatiroglu, Omer
dc.date.accessioned2020-12-19T19:34:23Z
dc.date.available2020-12-19T19:34:23Z
dc.date.issued2020
dc.identifier46en_US
dc.identifier.issn0340-9937
dc.identifier.issn1615-6692
dc.identifier.urihttps://doi.org/10.1007/s00059-020-04966-4
dc.identifier.urihttps://hdl.handle.net/11436/1071
dc.descriptionCetin, Mustafa/0000-0001-6342-436Xen_US
dc.descriptionWOS: 000545888200005en_US
dc.descriptionPubMed: 32632548en_US
dc.description.abstractBackground It is important to identify patients that are at high risk following primary percutaneous coronary intervention (P-PCI) for the treatment of ST-segment elevation myocardial infarction (STEMI). Left ventricular ejection fraction (LVEF) is the most important parameter obtained from transthoracic echocardiography (TTE) for risk stratification. the authors evaluated the value of pulmonary artery pressure (PAP) and left atrial volume index (LAVI) for the prediction of major adverse cardiovascular events (MACE) in patients with STEMI that underwent P-PCI. Methods A total of 92 patients that underwent P-PCI for STEMI were included in the study. All patients underwent TTE examination before discharge. the composite primary outcome of the study was all-cause mortality and new onset heart failure (HF) during an 8-year follow-up period. Results the mean age of patients was 61.6 +/- 12.4 years and 15 were female (16.3%). Major adverse cardiovascular events (MACE) defined as all-cause mortality and new onset HF occurred in 30 (41%) patients during a mean of 6 +/- 2.7 years of follow-up. in the backward multivariate Cox regression analysis LVEF (odds ratio [OR] = 0.933, 95% confidence interval [CI]: 0.876-0.994,p = 0.031), LAVI (OR = 1.069, 95%CI: 1.017-1.124,p = 0.009), PAP (OR = 1.137, 95% CI: 1.057-1.223,p = 0.001) and creatinine level (OR = 1.730, 95% CI: 1.350-1.223,p = 0.029) were found to independently predict MACE during long-term follow-up. Receiver operating characteristic (ROC) curve analysis was performed, revealing that sPAP >24.5 mm Hg had a sensitivity and specificity of 72 and 66%, respectively; LAVI >31 ml/m(2)had a sensitivity and specificity of 72.2 and 83.3%, respectively. Conclusion in patients that underwent P-PCI for the treatment for STEMI, LVEF, LAVI, PAP and creatinine level independently predicted all-cause mortality and new onset HF during long-term follow-up.en_US
dc.language.isoengen_US
dc.publisherUrban & Vogelen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectST segment elevation myocardial infarctionen_US
dc.subjectPrimary percutaneous coronary interventionen_US
dc.subjectLeft ventricule ejection fractionen_US
dc.subjectMajor adverse cardiovascular eventsen_US
dc.subjectPulmonary artery pressureen_US
dc.titleLeft atrial volume index and pulmonary arterial pressure predicted MACE among patients with STEMI during 8-year follow-up: experience from a tertiary centeren_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, :)en_US
dc.contributor.institutionauthorÖzer, Savaş
dc.contributor.institutionauthorÇetin, Mustafa
dc.identifier.doi10.1007/s00059-020-04966-4
dc.identifier.startpage367en_US
dc.identifier.startpage
dc.identifier.endpage374en_US
dc.relation.journalHerzen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster